IL98970A0 - Cyclopentane derivatives,processes for the preparation thereof and pharmaceutical compositions containing the same - Google Patents

Cyclopentane derivatives,processes for the preparation thereof and pharmaceutical compositions containing the same

Info

Publication number
IL98970A0
IL98970A0 IL98970A IL9897091A IL98970A0 IL 98970 A0 IL98970 A0 IL 98970A0 IL 98970 A IL98970 A IL 98970A IL 9897091 A IL9897091 A IL 9897091A IL 98970 A0 IL98970 A0 IL 98970A0
Authority
IL
Israel
Prior art keywords
processes
preparation
same
pharmaceutical compositions
compositions containing
Prior art date
Application number
IL98970A
Original Assignee
Schering Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Schering Ag filed Critical Schering Ag
Publication of IL98970A0 publication Critical patent/IL98970A0/en

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C405/00—Compounds containing a five-membered ring having two side-chains in ortho position to each other, and having oxygen atoms directly attached to the ring in ortho position to one of the side-chains, one side-chain containing, not directly attached to the ring, a carbon atom having three bonds to hetero atoms with at the most one bond to halogen, and the other side-chain having oxygen atoms attached in gamma-position to the ring, e.g. prostaglandins ; Analogues or derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D215/00—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems
    • C07D215/02—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom
    • C07D215/16—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D215/36—Sulfur atoms

Landscapes

  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicinal Preparation (AREA)

Abstract

The invention relates to cyclopentane derivatives of formula (I) and their salts with physiologically tolerables bases and the $g(a), $g(b) or $g(g)-cyclodextrin clathrates and the liposome-encapsulated compounds of formula (I), a process for producing them and their pharmaceutical use.
IL98970A 1990-07-27 1991-07-26 Cyclopentane derivatives,processes for the preparation thereof and pharmaceutical compositions containing the same IL98970A0 (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE4024347A DE4024347A1 (en) 1990-07-27 1990-07-27 CYCLOPENTANE DERIVATIVES, METHOD FOR THE PRODUCTION THEREOF AND THEIR PHARMACEUTICAL USE

Publications (1)

Publication Number Publication Date
IL98970A0 true IL98970A0 (en) 1992-07-15

Family

ID=6411402

Family Applications (1)

Application Number Title Priority Date Filing Date
IL98970A IL98970A0 (en) 1990-07-27 1991-07-26 Cyclopentane derivatives,processes for the preparation thereof and pharmaceutical compositions containing the same

Country Status (13)

Country Link
EP (1) EP0541594B1 (en)
JP (1) JPH06502390A (en)
AT (1) ATE122036T1 (en)
AU (1) AU8221291A (en)
CA (1) CA2088161A1 (en)
DE (3) DE4024347A1 (en)
DK (1) DK0541594T3 (en)
ES (1) ES2074721T3 (en)
IE (1) IE67507B1 (en)
IL (1) IL98970A0 (en)
PT (1) PT98464B (en)
WO (1) WO1992002495A1 (en)
ZA (1) ZA915905B (en)

Families Citing this family (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE4036140A1 (en) * 1990-11-09 1992-05-14 Schering Ag 9-HALOGEN-11SS-HYDROXY-PROSTAGLANDIN DERIVATIVES, METHOD FOR THE PRODUCTION THEREOF AND THEIR USE AS MEDICINAL PRODUCTS
AU687906B2 (en) * 1993-12-15 1998-03-05 Alcon Laboratories, Inc. Use of certain prostaglandin analogues to treat glaucoma and ocular hypertension
DE69809268T2 (en) * 1997-09-09 2003-08-28 Procter & Gamble AROMATIC C16-C20 SUBSTITUTED TETRAHYDRO PROSTAGLANDINS AND THEIR USE AS PROSTAGLANDIN F AGONISTS
DE69832513T2 (en) * 1997-09-09 2006-07-13 Duke University AROMATIC C16-C20 SUBSTITUTED TETRAHYDRO PROSTAGLANDINES USE AS FP AGONISTE
TR200000671T2 (en) * 1997-09-09 2000-07-21 The Procter & Gamble Company Aromatic C16-C20-substituted tetrahydro prostaglandins useful as FP agonists.
US6242493B1 (en) 1998-03-13 2001-06-05 Merck Frosst Canada & Co. Carboxylic acids and acylsulfonamides, compositions containing such compounds and methods of treatment
WO1999047497A2 (en) * 1998-03-13 1999-09-23 Merck Frosst Canada & Co. Carboxylic acids and acylsulfonamides, compositions containing such compounds and methods of treatment
MXPA01008955A (en) 1999-03-05 2002-04-24 Procter & Gamble C16.
US20020172693A1 (en) 2000-03-31 2002-11-21 Delong Michell Anthony Compositions and methods for treating hair loss using non-naturally occurring prostaglandins
US20020013294A1 (en) 2000-03-31 2002-01-31 Delong Mitchell Anthony Cosmetic and pharmaceutical compositions and methods using 2-decarboxy-2-phosphinico derivatives
US7323591B2 (en) * 2006-01-10 2008-01-29 Allergan, Inc. Substituted cyclopentanes or cyclopentanones as therapeutic agents
WO2009140205A2 (en) * 2008-05-15 2009-11-19 Allergan, Inc. Therapeutic substituted cyclopentanes
CN106928227B (en) * 2010-07-15 2020-06-30 浙江奥翔药业股份有限公司 Synthetic method of entecavir and intermediate compound thereof

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1431561A (en) * 1973-01-31 1976-04-07 Ici Ltd Cyclopentane derivatives
IT1053781B (en) * 1974-09-25 1981-10-10 Erba C S P A Ora Farmitalia OMEGA NOR CICLOALCIL 13.14 DEIDRO PROSTAGLANDINE
FR2349328A1 (en) * 1976-04-30 1977-11-25 Roussel Uclaf (11)-Deoxy-prostaglandin analogues - for use as hypotensives, smooth-muscle contractants and luteolytic agents
DE3126924A1 (en) * 1981-07-03 1983-01-20 Schering Ag, 1000 Berlin Und 4619 Bergkamen 9-FLUOR PROSTAGLAND DERIVATIVES, METHOD FOR THE PRODUCTION AND USE AS A MEDICINAL PRODUCT
DE3325175A1 (en) * 1983-07-08 1985-01-17 Schering AG, 1000 Berlin und 4709 Bergkamen 11-HALOGEN PROSTANE DERIVATIVES, METHOD FOR THE PRODUCTION THEREOF AND THEIR USE AS MEDICINAL PRODUCTS
DE3510978A1 (en) * 1985-03-22 1986-09-25 Schering AG, Berlin und Bergkamen, 1000 Berlin NEW 9-HALOGEN PROSTAGLANDINE, METHOD FOR THE PRODUCTION THEREOF AND THEIR USE AS MEDICINAL PRODUCTS
IL87116A (en) * 1987-07-17 1993-03-15 Schering Ag 9-halogen-(z)-prostaglandin derivatives and pharmaceutical compositions containing the same
DE3923797A1 (en) * 1989-07-14 1991-01-24 Schering Ag 9-FLUOR-PROSTAGLANDIN DERIVATIVES, METHOD FOR THE PRODUCTION THEREOF AND THEIR PHARMACEUTICAL USE

Also Published As

Publication number Publication date
EP0541594B1 (en) 1995-05-03
AU8221291A (en) 1992-03-02
IE912654A1 (en) 1992-01-29
ZA915905B (en) 1992-04-29
CA2088161A1 (en) 1992-01-28
DE4191848D2 (en) 1993-10-07
EP0541594A1 (en) 1993-05-19
WO1992002495A1 (en) 1992-02-20
PT98464B (en) 1997-10-31
DK0541594T3 (en) 1995-10-02
JPH06502390A (en) 1994-03-17
PT98464A (en) 1992-05-29
DE4024347A1 (en) 1992-01-30
IE67507B1 (en) 1996-04-03
DE59105400D1 (en) 1995-06-08
ES2074721T3 (en) 1995-09-16
ATE122036T1 (en) 1995-05-15

Similar Documents

Publication Publication Date Title
CA2091360A1 (en) Mometasone furoate monohydrate, process for making same and pharmaceutical compositions
IL117091A (en) Methylphenyloxazolidinone derivatives pharmaceutical compositions containing the same and processes for the preparation threreof
IL98970A0 (en) Cyclopentane derivatives,processes for the preparation thereof and pharmaceutical compositions containing the same
ATE8401T1 (en) ANTHRACYCLINE GLYCOSIDES, PROCESS FOR THEIR PRODUCTION, INTERMEDIATE PRODUCTS AND THEIR PRODUCTION AND MEDICINAL PRODUCTS.
MX9601635A (en) Anthracycline derivatives.
HUT60275A (en) Process for producing 7-acyl-3-(substituted carbamoyloxy)-cef-3-em-4-carboxylic acid derivatives and pharmaceutical compositions comprising such compounds
WO1992009574A3 (en) Poly-aminopyrrolecarboxamido derivatives, processes for their preparation and pharmaceutical compositions containing them
IL98969A0 (en) Cyclopentene derivatives,processes for the preparation thereof and pharmaceutical compositions containing the same
ES2049186A1 (en) Benzofuranylimidazole derivatives and therapeutical compositions containing the same
GR3019568T3 (en) Cyclopentane ether derivatives, methods for preparing them and their use in pharmaceuticals
ATE40380T1 (en) ANTHRACYCLINE COMPOUND, PROCESS FOR THEIR PRODUCTION, ITS PHARMACEUTICAL COMPOSITION AND ITS USE AS A MEDICINAL PRODUCT.
AU1466592A (en) Gem-diphosphonic acid nitrosocarbamoyl derivatives, a process for the preparation thereof and pharmaceutical compositions containing them